Sana Biotechnology Inc (SANA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Steven D. Harr
Employees:
380
188 EAST BLAINE STREET, SUIT 400, SEATTLE, WA 98102
(206) 701-7914

Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia. SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus. SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease.

Data derived from most recent annual or quarterly report
Market Cap 1.19 Billion Shares Outstanding191.361 Million Avg 30-day Volume 1.511 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.69
Price to Revenue0.0 Debt to Equity0.3709 EBITDA-309.193 Million
Price to Book Value1.4601 Operating Margin0.0 Enterprise Value418.508 Million
Current Ratio3.599 EPS Growth-1.139 Quick Ratio3.399
1 Yr BETA 2.2373 52-week High/Low 9.55 / 2.99 Profit Margin0.0
Operating Cash Flow Growth-4.577 Altman Z-Score-1.9628 Free Cash Flow to Firm -353.743 Million
Earnings Report2023-08-03

View recent insider trading info

Funds Holding SANA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SANA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

545.2 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND V, L.P.

FLAGSHIP V VENTURELABS RX FUND, L.P.

AFEYAN NOUBAR

  • 10% Owner
59,027,804 2023-05-24 1

WILLIAMS DOUGLAS E EVP & PRESIDENT, R&D

  • Officer
0 2023-04-10 2

WILDEROTTER MARY AGNES

  • Director
2,314 2023-04-05 1

BISHOP HANS EDGAR

  • Director
5,760,888 2023-04-05 4

MULLIGAN RICHARD HEAD OF SANAX

  • Officer
  • Director
0 2023-03-02 1

CASSIDY BERNARD J EVP & GENERAL COUNSEL

  • Officer
0 2023-03-02 4

HARR STEVE PRESIDENT & CEO

  • Officer
  • Director
0 2023-03-02 1

HARDY NATHAN EVP, CHIEF FINANCIAL OFFICER

  • Officer
0 2023-03-02 1

HORDO CHRISTIAN EVP, CHIEF BUSINESS OFFICER

  • Officer
0 2023-03-02 1

NELSEN ROBERT

  • Director
  • 10% Owner
44,056,353 2023-01-05 3

MACDONALD JAMES J. EVP & GENERAL COUNSEL

  • Officer
682,162 2022-06-13 1

YANG PATRICK Y

  • Director
239,250 2022-06-06 0

COLE DOUGLAS G.

  • Director
65,000 2022-06-06 0

BILENKER JOSHUA H.

  • Director
65,000 2022-06-06 0

REICIN ALISE

  • Director
65,000 2022-06-06 0

SEITZ MICHELLE

  • Director
65,000 2022-06-06 0

AGARWAL SUNIL EVP, HEAD OF DEVELOPMENT & CMO

  • Officer
1,800,000 2022-03-03 0

ARCH VENTURE FUND X, L.P.

CRANDELL KEITH

BYBEE CLINTON

BUROW KRISTINA

GILLIS STEVEN

  • 10% Owner
44,042,500 2021-02-08 0

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC

FLAGSHIP V VENTURELABS RX FUND, L.P.

FLAGSHIP VENTURES FUND V, L.P.

FLAGSHIP PIONEERING INC.

FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC

FLAGSHIP PIONEERING FUND VI, L.P.

FLAGSHIP VENTURELABS V MANAGER LLC

FLAGSHIP VENTURELABS V LLC

AFEYAN NOUBAR

  • 10% Owner
34,239,018 2021-02-08 0

ARCH VENTURE FUND X, L.P.

ARCH VENTURE FUND IX, L.P.

ARCH VENTURE FUND IX OVERAGE, L.P.

ARCH VENTURE FUND X OVERAGE, L.P.

ARCH VENTURE PARTNERS IX, L.P.

ARCH VENTURE PARTNERS IX OVERAGE, L.P.

ARCH VENTURE PARTNERS X, L.P.

ARCH VENTURE PARTNERS X OVERAGE, L.P.

ARCH VENTURE PARTNERS IX, LLC

ARCH VENTURE PARTNERS X, LLC

  • 10% Owner
44,042,500 2021-02-08 0

VON MALTZAHN GEOFFREY

  • Director
1,830,610 2021-02-08 0

ARCH VENTURE FUND X, L.P.

ARCH VENTURE FUND IX, L.P.

ARCH VENTURE FUND IX OVERAGE, L.P.

ARCH VENTURE FUND X OVERAGE, L.P.

ARCH VENTURE PARTNERS IX OVERAGE, L.P.

ARCH VENTURE PARTNERS X, L.P.

ARCH VENTURE PARTNERS X OVERAGE, L.P.

ARCH VENTURE PARTNERS IX, LLC

ARCH VENTURE PARTNERS X, LLC

  • 10% Owner
292,500 2021-02-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC - > 10% Owner by flagship v venturelabs rx fund, l.p.

FLAGSHIP VENTURES FUND V, L.P. - > 10% Owner by flagship v venturelabs rx fund, l.p.

FLAGSHIP V VENTURELABS RX FUND, L.P. - > 10% Owner by flagship v venturelabs rx fund, l.p.

AFEYAN NOUBAR - > 10% Owner by flagship v venturelabs rx fund, l.p.

2023-05-26 20:00:11 -0400 2023-05-26 S 9,330 $6.23 d 1,425,334 indirect 3.7931 3.7931 2 0.0 1

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC - > 10% Owner by flagship ventures fund v, l.p.

FLAGSHIP VENTURES FUND V, L.P. - > 10% Owner by flagship ventures fund v, l.p.

FLAGSHIP V VENTURELABS RX FUND, L.P. - > 10% Owner by flagship ventures fund v, l.p.

AFEYAN NOUBAR - > 10% Owner by flagship ventures fund v, l.p.

2023-05-26 20:00:11 -0400 2023-05-26 S 72,670 $6.23 d 11,101,994 indirect 3.7931 3.7931 2 0.0 1

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC - > 10% Owner by flagship v venturelabs rx fund, l.p.

FLAGSHIP VENTURES FUND V, L.P. - > 10% Owner by flagship v venturelabs rx fund, l.p.

FLAGSHIP V VENTURELABS RX FUND, L.P. - > 10% Owner by flagship v venturelabs rx fund, l.p.

AFEYAN NOUBAR - > 10% Owner by flagship v venturelabs rx fund, l.p.

2023-05-26 20:00:11 -0400 2023-05-25 S 13,127 $6.35 d 1,434,664 indirect 3.7931 3.7931 2 0.0 1

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC - > 10% Owner by flagship ventures fund v, l.p.

FLAGSHIP VENTURES FUND V, L.P. - > 10% Owner by flagship ventures fund v, l.p.

FLAGSHIP V VENTURELABS RX FUND, L.P. - > 10% Owner by flagship ventures fund v, l.p.

AFEYAN NOUBAR - > 10% Owner by flagship ventures fund v, l.p.

2023-05-26 20:00:11 -0400 2023-05-25 S 102,245 $6.35 d 11,174,664 indirect 3.7931 3.7931 2 0.0 1

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC - > 10% Owner by flagship v venturelabs rx fund, l.p.

FLAGSHIP VENTURES FUND V, L.P. - > 10% Owner by flagship v venturelabs rx fund, l.p.

FLAGSHIP V VENTURELABS RX FUND, L.P. - > 10% Owner by flagship v venturelabs rx fund, l.p.

AFEYAN NOUBAR - > 10% Owner by flagship v venturelabs rx fund, l.p.

2023-05-26 20:00:11 -0400 2023-05-24 S 39,580 $6.57 d 1,447,791 indirect 3.7931 3.7931 2 0.0 1

FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC - > 10% Owner by flagship ventures fund v, l.p.

FLAGSHIP VENTURES FUND V, L.P. - > 10% Owner by flagship ventures fund v, l.p.

FLAGSHIP V VENTURELABS RX FUND, L.P. - > 10% Owner by flagship ventures fund v, l.p.

AFEYAN NOUBAR - > 10% Owner by flagship ventures fund v, l.p.

2023-05-26 20:00:11 -0400 2023-05-24 S 308,290 $6.57 d 11,276,909 indirect 3.7931 3.7931 2 0.0 1

WILLIAMS DOUGLAS E - Officer EVP & PRESIDENT, R&D

2023-04-11 16:26:28 -0400 2023-04-10 A 1,100,000 a 1,100,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SANA BIOTECHNOLOGY INC SANA 2023-06-06 22:15:03 UTC 3.3979 1.6721 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 21:45:05 UTC 3.3979 1.6721 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 21:15:04 UTC 3.3979 1.6721 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 20:45:04 UTC 3.3979 1.6721 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 20:15:04 UTC 3.3979 1.6721 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 19:45:04 UTC 3.3979 1.6721 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 19:15:03 UTC 3.3979 1.6721 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 18:45:04 UTC 3.3787 1.6913 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 18:15:04 UTC 3.3787 1.6913 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 17:45:04 UTC 3.3787 1.6913 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 17:15:04 UTC 3.3787 1.6913 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 16:45:04 UTC 3.1517 1.9083 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 16:15:03 UTC 3.1517 1.9083 150000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 15:45:04 UTC 3.1517 1.9083 85000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 15:15:04 UTC 3.1517 1.9083 85000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 14:45:04 UTC 2.8923 2.1677 100000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 14:15:03 UTC 2.8923 2.1677 90000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 13:45:03 UTC 2.8923 2.1677 100000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 13:15:03 UTC 2.8923 2.1677 100000
SANA BIOTECHNOLOGY INC SANA 2023-06-06 12:45:05 UTC 2.8923 2.1677 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments